Magnesium administration may improve heart rate variability in patients with heart failure

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 9, 2009, Pages 641-645

  Almoznino Sarafian, D ^a   Sarafian, G ^b   Berman, S ^a   Shteinshnaider, M ^a   Tzur, I ^a   Cohen, N ^a   Gorelik, O ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Heart failure; Heart rate variability; Magnesium

Indexed keywords

MAGNESIUM;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONLINEAR SYSTEM; PROGNOSIS; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME;

AGED; COMORBIDITY; CYTOSOL; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART FAILURE, SYSTOLIC; HEART RATE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; NONLINEAR DYNAMICS; PROGNOSIS; TREATMENT OUTCOME;

EID: 70350567766     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.12.002     Document Type: Article

References (32)

1. Goldberger A.L. Fractal variability versus pathologic periodicity: complexity loss and stereotypy in disease. Perspect Biol Med 40 (1997) 543-561
2. Nolan J., Batin P.D., Andrews R., Lindsay S.J., Brooksby P., Mullen M., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98 (1998) 1510-1516
3. Chattipakorn N., Incharoen T., Kanlop N., and Chattipakorn S. Heart rate variability in myocardial infarction and heart failure. Int J Cardiol 120 (2007) 289-296 10.1016/j.ijcard.2006.11.221
4. Bilchick K.C., Fetics B., Djoukeng R., Fisher S.G., Fletcher R.D., Singh S.N., et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol 90 (2002) 24-28 10.1016/S0002-9149(02)02380-9
5. Aronson D., Mittleman M.A., and Burger A.J. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol 93 (2004) 59-63 10.1016/j.amjcard.2003.09.013
6. Grassberger P., and Procaccia I. Measuring the strangeness of strange attractors. Physica D 9 (1983) 189-208
7. Lombardi F. Chaos theory, heart rate variability, and arrhythmic mortality. Circulation 101 (2000) 8-10
8. Voss A., Kurths J., Kleiner H.J., Witt A., Wessel N., Saparin P., et al. The application of methods of non-linear dynamics for the improved and predictive recognition of patients threatened by sudden cardiac death. Cardiovasc Res 31 (1996) 419-433 10.1016/S0008-6363(96)00008-9
9. Gademan M.G., Swenne C.A., Verwey H.F., van der Laarse A., Maan A.C., van de Vooren H., et al. Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure. J Card Fail 13 (2007) 294-303 10.1016/j.cardfail.2006.12.006
10. Gilman M.P., Floras J.S., Usui K., Kaneko Y., Leung R.S., and Bradley T.D. Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 114 (2008) 243-249
11. Gilliam III F.R., Kaplan A.J., Black J., Chase K.J., and Mullin C.M. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry. Pacing Clin Electrophysiol 30 (2007) 56-64
12. Aronson D., and Burger A.J. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure. Am Heart J 148 (2004) e16 10.1016/j.ahj.2004.05.027
13. Camm A.J., Pratt C.M., Schwartz P.J., Al-Khalidi H.R., Spyt M.J., Holroyde M.J., et al. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 109 (2004) 990-996
14. Akdeniz B., Guneri S., Savas I.Z., Aslan O., Baris N., Badak O., et al. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure. Int Heart J 47 (2006) 565-573
15. Al-Ghamdi S.M., Cameron E.C., and Sutton R.A. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 24 (1994) 737-752
16. Chakraborti S., Chakraborti T., Mandal M., Mandal A., Das S., and Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 238 (2002) 163-179
17. Wester P.O. Electrolyte balance in heart failure and the role for magnesium ions. Am J Cardiol 70 (1992) 44C-49C
18. Douban S., Brodsky M.A., Whang D.D., and Whang R. Significance of magnesium in congestive heart failure. Am Heart J 132 (1996) 664-671 10.1016/S0002-8703(96)90253-7
19. Bobkowski W., Zachwieja J., Siwińska A., Mroziński B., Rzeźnik-Bieniaszewska A., and Maciejewski J. Influence of autonomic nervous system on electrolyte abnormalities in children with mitral valve prolapse. Pol Merkur Lekarski 14 (2003) 220-223
20. Takase B., Akima T., Satomura K., Ohsuzu F., Mastui T., Ishihara M., et al. Effects of chronic sleep deprivation on autonomic activity by examining heart rate variability, plasma catecholamine, and intracellular magnesium levels. Biomed Pharmacother 58 (2004) S35-S39
21. Averbukh Z., Rosenberg R., Galperin E., Berman S., Cohn M., Cohen N., et al. Cell-associated magnesium and QT dispersion in hemodialysis patients. Am J Kidney Dis 41 (2003) 196-202
22. Reinhart R.A. Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 148 (1988) 2415-2420
23. 2+ acting at an EF-hand motif in the COOH-terminal domain. J Gen Physiol 126 (2005) 311-323
24. Chen P.S., and Tan A.Y. Autonomic nerve activity and atrial fibrillation. Heart Rhythm 4 (2007) S61-S64 10.1016/j.hrthm.2006.12.006
25. Ryzen E., Elkayam U., and Rude R.K. Low blood mononuclear cell magnesium in intensive cardiac care unit patients. Am Heart J 111 (1986) 475-480
26. Grochowicz U., Wolk R., Bednarz B., Budaj A., and Ceremuzynski L. Clinical characteristics of patients with increased urinary excretion of adrenaline in mild to moderate heart failure. Clin Cardiol 24 (2001) 209-213
27. Samejima H., Tanabe K., Suzuki N., Omiya K., and Murayama M. Magnesium dynamics and sympathetic nervous system activity in patients with chronic heart failure. Jpn Circ J 63 (1999) 267-273
28. Sesay M., Tauzin-Fin P., Gosse P., Ballanger P., and Maurette P. Real-time heart rate variability and its correlation with plasma catecholamines during laparoscopic adrenal pheochromocytoma surgery. Anesth Analg 106 (2008) 164-170
29. Parikka H., Toivonen L., Naukkarinen V., Tierala I., Pohjola-Sintonen S., Heikkilä J., et al. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J 20 (1999) 111-120
30. Bashir Y., Sneddon J.F., Staunton H.A., Haywood G.A., Simpson I.A., McKenna W.J., et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 72 (1993) 1156-1162 10.1016/0002-9149(93)90986-M
31. Shechter M., Sharir M., Labrador M.J., Forrester J., Silver B., and Bairey Merz C.N. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102 (2000) 2353-2358
32. McBride B.F., Min B., Kluger J., Guertin D., Henyan N.N., Coleman C.I., et al. An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Ann Noninvasive Electrocardiol 11 (2006) 163-169